KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teladoc Health (TDOC) Common Equity (2016 - 2026)

Teladoc Health's Common Equity history spans 14 years, with the latest figure at $1.3 billion for Q1 2026.

  • On a quarterly basis, Common Equity fell 6.36% to $1.3 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $1.3 billion, a 6.36% decrease, with the full-year FY2025 number at $1.4 billion, down 7.07% from a year prior.
  • Common Equity hit $1.3 billion in Q1 2026 for Teladoc Health, down from $1.4 billion in the prior quarter.
  • Over the last five years, Common Equity for TDOC hit a ceiling of $9.1 billion in Q1 2022 and a floor of $1.3 billion in Q1 2026.
  • Historically, Common Equity has averaged $2.7 billion across 5 years, with a median of $2.3 billion in 2024.
  • Biggest five-year swings in Common Equity: crashed 85.62% in 2022 and later rose 0.79% in 2023.
  • Tracing TDOC's Common Equity over 5 years: stood at $2.3 billion in 2022, then rose by 0.79% to $2.3 billion in 2023, then plummeted by 35.9% to $1.5 billion in 2024, then fell by 7.07% to $1.4 billion in 2025, then dropped by 3.56% to $1.3 billion in 2026.
  • Business Quant data shows Common Equity for TDOC at $1.3 billion in Q1 2026, $1.4 billion in Q4 2025, and $1.4 billion in Q3 2025.